National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 38037-38038 [E9-18226]
Download as PDF
Federal Register / Vol. 74, No. 145 / Thursday, July 30, 2009 / Notices
Contact: Shelly Hara, Substance
Abuse and Mental Health Services
Administration, 1 Choke Cherry Road,
Room 8–1081, Rockville, MD 20857;
telephone: (240) 276–2321; E-mail:
shelly.hara@samhsa.hhs.gov.
Dated: July 24, 2009.
Toian Vaughn,
Committee Management Officer, Substance
Abuse and Mental Health, Services
Administration.
[FR Doc. E9–18187 Filed 7–29–09; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
erowe on DSK5CLS3C1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Immunobiology of
Xenotransplantation.
Date: September 18, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, 3264, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Maryam Feili-Hariri, PhD,
Scientific Review Officer, Immunology
Review Branch, Scientific Review Program,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, 301–402–5658,
haririmf@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–18225 Filed 7–29–09; 8:45 am]
BILLING CODE 4140–01–P
VerDate Nov<24>2008
15:34 Jul 29, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA–
F Special Emphasis Panel.
Date: August 3, 2009.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Nadine Rogers, PhD,
Scientific Review Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Boulevard, Bethesda,
MD 20892–8401, 301–402–2105,
rogersn2@nida.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Diversity-promoting Institutions’ Drug Abuse
Research Development Program.
Date: August 3, 2009.
Time: 1 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Nadine Rogers, PhD,
Scientific Review Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Boulevard, Bethesda,
MD 20892–8401, 301–402–2105,
rogersn2@nida.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
38037
Dated: July 23, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–18017 Filed 7–29–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the National
Diabetes and Digestive and Kidney
Diseases Advisory Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: September 9, 2009.
Open: 8:30 a.m. to 11:45 a.m.
Agenda: To present the Director’s Report
and other scientific presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 4:15 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council Diabetes, Endocrinology, and
Metabolic Diseases Subcommittee.
E:\FR\FM\30JYN1.SGM
30JYN1
erowe on DSK5CLS3C1PROD with NOTICES
38038
Federal Register / Vol. 74, No. 145 / Thursday, July 30, 2009 / Notices
Date: September 9, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council Digestive Diseases and Nutrition
Subcommittee.
Date: September 9, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council Kidney, Urologic, and Hematologic
Diseases Subcommittee.
Date: September 9, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 7, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 7, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs and hotel and airport
VerDate Nov<24>2008
15:34 Jul 29, 2009
Jkt 217001
shuttles, will be inspected before being
allowed on campus. Visitors will be asked to
show one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the purpose
of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.niddk.nih.gov/fund/divisions/DEA/
Council/coundesc.htm., where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: July 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–18226 Filed 7–29–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Part C Early Intervention Services
Grant
AGENCY: Health Resources and Services
Administration (HRSA), HHS.
ACTION: Notice of Noncompetitive
Award to Wyoming Department of
Health.
SUMMARY: HRSA will be awarding
noncompetitively Part C Ryan White
HIV/AIDS program funds to support
comprehensive primary care services for
persons living with HIV/AIDS including
primary medical care, laboratory testing,
oral health care, outpatient mental
health and substance abuse treatment,
specialty and subspecialty care, referrals
for health and support services, and
adherence monitoring/education
services to the Wyoming Department of
Health in order to ensure continuity of
critical HIV medical care and treatment
services, and to avoid a disruption of
HIV clinical care to clients in the State
of Wyoming.
SUPPLEMENTARY INFORMATION:
Grantee of record: Equality State
Infection Foundation. Intended
recipient of the award: Wyoming
Department of Health.
Amount of the award: Wyoming
Department of Health will receive
$182,812 fiscal year 2009 funds to cover
9 months of support to ensure ongoing
clinical services to the target population
and provide seamless services to the
State of Wyoming.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Authority: Section 2651 of the Public
Health Service Act, 42 U.S.C. 300ff–51.
CFDA Number: 93.918.
Project period: July 1, 2009, to March
31, 2010. The period of support for the
replacement award is from July 1, 2009,
to March 31, 2010.
Justification for the Exception to
Competition:
Critical funding for HIV medical care
and treatment services to clients in the
State of Wyoming will be continued
through a noncompetitive award to the
Wyoming Department of Health, as it
has the fiscal and administrative
infrastructure to administer the Part C
Grant. This is a temporary replacement
award, as the previous grant recipient
serving this population notified HRSA
that it could not continue providing
services after March 31, 2009. HRSA
identified the Wyoming Department of
Health as the best qualified entity for
this temporary grant, as it is the current
Ryan White Part B Grantee of record
that serves as the State/regional HIV
care consortia for funding services such
as primary care, case management,
support services and the AIDS Drug
Assistance Program. The Wyoming
Department of Health can ensure
comprehensive services are provided
including primary medical care,
antiretroviral therapies, medical case
management, prevention education and
medication adherence teaching, referrals
for mental health, substance abuse and
dental services; on-site social services
with linkages to community HIV case
management services; and referrals to
HIV counseling and testing sites. The
Wyoming Department of Health is
willing and able to provide critical
services with the least amount of
disruption to the service population
while the service area is re-competed.
This award will cover the time period
from July 1, 2009, through March 31,
2010. This service area will be included
in the upcoming competition for the
Part C HIV Early Intervention Services
competing application process for
project periods starting April 1, 2010.
FOR FURTHER INFORMATION CONTACT: Dora
Ober, Chief, Western Branch, Division
of Community Based Programs, HIV/
AIDS Bureau, HRSA, 5600 Fishers Lane,
Rockville, Maryland 20857; via e-mail
dober@hrsa.gov, or via telephone, 301–
443–0759.
Dated: July 23, 2009.
Mary K. Wakefield,
Administrator.
[FR Doc. E9–18123 Filed 7–29–09; 8:45 am]
BILLING CODE 4165–15–P
E:\FR\FM\30JYN1.SGM
30JYN1
Agencies
[Federal Register Volume 74, Number 145 (Thursday, July 30, 2009)]
[Notices]
[Pages 38037-38038]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-18226]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of meetings of the
National Diabetes and Digestive and Kidney Diseases Advisory Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council.
Date: September 9, 2009.
Open: 8:30 a.m. to 11:45 a.m.
Agenda: To present the Director's Report and other scientific
presentations.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: 4:15 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council Diabetes, Endocrinology, and Metabolic
Diseases Subcommittee.
[[Page 38038]]
Date: September 9, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council Digestive Diseases and Nutrition
Subcommittee.
Date: September 9, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 6, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 6, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council Kidney, Urologic, and Hematologic Diseases
Subcommittee.
Date: September 9, 2009.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 7, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 7, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs and hotel and airport shuttles, will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm., where an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: July 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-18226 Filed 7-29-09; 8:45 am]
BILLING CODE 4140-01-P